Our Blog

The Microbiome as a Functional Organ

June 2, 2021

Ethos Discovery's ultimate goal is to discover and develop novel diagnostics and therapeutics for intestinal dysbiosis, and ultimately to be able to predict and even prevent certain chronic diseases. This will lead to prolonged lifespan and health-span for domestic animals and also for human beings.

Ethos Discovery vs Canine Hemangiosarcoma

February 12, 2021

Ethos-PUSH will serve as the largest collection of canine hemangiosarcoma biospecimens in the world. These biospecimens will be made available to independent collaborators with the goal of further understanding the genomics, epigenomics, and biology of hemangiosarcoma.

Diagnosis, Treatment and Future Study Direction in Dogs with Intestinal Dysbiosis

September 11, 2020

A patient with intestinal dysbiosis can have decreased appetite, diarrhea, vomiting, or a variety of other clinical signs.

Hemangiosarcoma – Developing New Treatment Options

August 12, 2020

Ethos Discovery hopes to improve the outcome for dogs with hemangiosarcoma and take a similar path as to that of human childhood leukemia, which through significant research efforts went from a commonly fatal disease to a commonly cured disease.

Rachael Ray Talks to Dr. Khanna

June 18, 2020

Dr. Chand Khanna, joined Rachael Ray and internal medicine specialist Dr. William Li to talk about the bridge between animal and human health, and how research for one can positively impact the other

Improving Survival Rates in Septic Patients

June 11, 2020

Sepsis is the result of an infection that enters the bloodstream and causes a severe inflammatory reaction. It can lead to many alterations around the body that can cause significant difficulty in the diagnosis and treatment of the underlying infection. Ethos Discovery hopes that its research will contribute to an improvement in patient survival rates, which would not only be beneficial to veterinary patients, but to human patients as well.

How Hemangiosarcoma Broke Our Hearts

May 27, 2020

We hope that Dakota’s story helps those who are unfamiliar with the rapid progression of Hemangiosarcoma to better understand it.

About Intestinal Dysbiosis and why it is a Priority for Ethos Discovery

April 29, 2020

Intestinal dysbiosis is an alteration in the composition and/or richness of the normal bacteria that are found in the gastrointestinal tract (microbiota). The effect of intestinal dysbiosis on the progression of various diseases is currently lacking in both human and veterinary medicine. Ethos Discovery now asks what the influence of intestinal dysbiosis is on a variety of non-GI diseases in veterinary patients.

How Clinical Trials Have Intersected with my Practice of Clinical Medicine

March 25, 2020

Our President Dr. Chand Khanna shares his thoughts on his career as a practicing veterinary oncologiest, and his approach to innovation and clinical trials. The option of therapeutics only available through clinical trials has been a key feature of his practice of clinical medicine which has delivered many favorable intended and unintended consequences.

A Necessary Shift in Perspective: A First Step Towards Curative Outcomes in Veterinary Oncology

March 18, 2020

Ethos Discovery seeks to deliver curative outcomes for pet animals with cancer. Given that the term "cure" has been historically avoided, we do not document or recognize curative outcomes when they occur. As a first step towards raising cancer survivorship, a change in perspective and our assessment of existing data is needed.

Precision Medicine and Canine Hemangiosarcoma

April 30, 2019

There are limited therapeutic options for the treatment of hemangiosarcoma, with none currently providing a significant opportunity for long-term survival. Ethos Discovery’s previous work in hemangiosarcoma has taught us that hemangiosarcoma is not a single cancer, but rather at least four different subtypes of cancer.